Research Papers:

Characterization of RNA editome in primary and metastatic lung adenocarcinomas

Lihua Peng, Leo J. Lee, Heng Xiong, Hong Su, Junhua Rao, Dakai Xiao, Jianxing He, Kui Wu and Dongbing Liu _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:11517-11529. https://doi.org/10.18632/oncotarget.14076

Metrics: PDF 1666 views  |   HTML 2116 views  |   ?  


Lihua Peng1,2,*, Leo J Lee2,3,*, Heng Xiong2, Hong Su2, Junhua Rao2, Dakai Xiao4,5,6, Jianxing He4,5,7, Kui Wu2,8, Dongbing Liu2

1BGI Education Center, University of Chinese Academy of Sciences, Shenzhen 518083, China

2BGI-Shenzhen, Shenzhen 518083, China

3Department of Electrical and Computer Engineering, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3G4, Canada

4Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China

5Guangzhou Institute of Respiratory Disease & State Key Laboratory of Respiratory Disease, Guangzhou 510120, China

6Research Center for Translational Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China

7National Clinical Research Center for Respiratory Disease, Guangzhou 510120, China

8Department of Biology, University of Copenhagen, Copenhagen N DK-2200, Denmark

*These authors have contributed equally to this work

Correspondence to:

Dongbing Liu, email: [email protected]

Keywords: lung adenocarcinoma, RNA editing, hyper-editing, primary, metastatic

Received: May 27, 2016     Accepted: November 21, 2016     Published: December 21, 2016


RNA editing results in post-transcriptional modification and could potentially contribute to carcinogenesis. However, RNA editing in advanced lung adenocarcinomas has not yet been studied. Based on whole genome and transcriptome sequencing data, we identified 1,071,296 RNA editing events from matched normal, primary and metastatic samples contributed by 24 lung adenocarcinoma patients, with 91.3% A-to-G editing on average, and found significantly more RNA editing sites in tumors than in normal samples. To investigate cancer relevant editing events, we detected 67,851 hyper-editing sites in primary and 50,480 hyper-editing sites in metastatic samples. 46 genes with hyper-editing in coding regions were found to result in amino acid alterations, while hundreds of hyper-editing events in non-coding regions could modulate splicing or gene expression, including genes related to tumor stage or clinic prognosis. Comparing RNA editome of primary and metastatic samples, we also discovered hyper-edited genes that may promote metastasis development. These findings showed a landscape of RNA editing in matched normal, primary and metastatic tissues of lung adenocarcinomas for the first time and provided new insights to understand the molecular characterization of this disease.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14076